Wu LX - Search Results

1

PD-L1 expression level in different thymoma stages and thymic carcinoma: a meta-analysis.

Chen HF, Wu LX, Li XF, Zhu YC, Pan WW, Wang WX, Xu CW, Huang JH, Wu MH, Du KQ. Chen HF, et al. Among authors: wu lx, wu mh. Tumori. 2020 Aug;106(4):306-311. doi: 10.1177/0300891620915788. Epub 2020 May 5. Tumori. 2020. PMID: 32366210

2

Concurrent ROS1 gene rearrangement and KRAS mutation in lung adenocarcinoma: A case report and literature review.

Zhu YC, Lin XP, Li XF, Wu LX, Chen HF, Wang WX, Xu CW, Shen JF, Wei JG, Du KQ. Zhu YC, et al. Among authors: wu lx. Thorac Cancer. 2018 Jan;9(1):159-163. doi: 10.1111/1759-7714.12518. Epub 2017 Oct 3. Thorac Cancer. 2018. PMID: 28971587 Free PMC article.

3

Association between BIM polymorphism and lung cancer outcomes: a meta-analysis.

Li XF, Wu LX, Chen HF, Zhu YC, Wang WX, Xu CW, Lin XP, Xie DF, Du KQ. Li XF, et al. Among authors: wu lx. Cell Mol Biol (Noisy-le-grand). 2018 Aug 30;64(11):92-96. Cell Mol Biol (Noisy-le-grand). 2018. PMID: 30213299

4

A meta-analysis of association between serum iron levels and lung cancer risk.

Chen HF, Wu LX, Li XF, Zhu YC, Wang WX, Xu CW, Xie DF, Huang JH, Du KQ. Chen HF, et al. Among authors: wu lx. Cell Mol Biol (Noisy-le-grand). 2018 Oct 30;64(13):33-37. Cell Mol Biol (Noisy-le-grand). 2018. PMID: 30403607

5

Intestinal metastasis from primary ROS1-positive lung adenocarcinoma cancer patients responding to crizotinib.

Chen HF, Zhang QX, Zhu YC, Du KQ, Li XF, Wu LX, Wang WX, Xu CW. Chen HF, et al. Among authors: wu lx. Onco Targets Ther. 2018 Nov 5;11:7821-7825. doi: 10.2147/OTT.S178985. eCollection 2018. Onco Targets Ther. 2018. PMID: 30464529 Free PMC article.

6

Combined detection of CEA and CA125 for the diagnosis for lung cancer: A meta-analysis.

Wu LX, Li XF, Chen HF, Zhu YC, Wang WX, Xu CW, Xie DF, Wan Y, Du KQ. Wu LX, et al. Cell Mol Biol (Noisy-le-grand). 2018 Dec 31;64(15):67-70. Cell Mol Biol (Noisy-le-grand). 2018. PMID: 30672447

7

Clinicopathological features and clinical efficacy of crizotinib in Chinese patients with ROS1-positive non-small cell lung cancer.

Zhu YC, Zhang XG, Lin XP, Wang WX, Li XF, Wu LX, Chen HF, Xu CW, Du KQ. Zhu YC, et al. Among authors: wu lx. Oncol Lett. 2019 Mar;17(3):3466-3474. doi: 10.3892/ol.2019.9949. Epub 2019 Jan 18. Oncol Lett. 2019. PMID: 30867785 Free PMC article.

8

Ginsenoside compound K inhibits growth of lung cancer cells via HIF-1α-mediated glucose metabolism.

Chen HF, Wu LX, Li XF, Zhu YC, Wang WX, Xu CW, Huang ZZ, Du KQ. Chen HF, et al. Among authors: wu lx. Cell Mol Biol (Noisy-le-grand). 2019 Apr 30;65(4):48-52. Cell Mol Biol (Noisy-le-grand). 2019. PMID: 31078152

9

Eye metastasis in lung adenocarcinoma mimicking anterior scleritis: A case report.

Chen HF, Wang WX, Li XF, Wu LX, Zhu YC, Du KQ, Xu CW. Chen HF, et al. Among authors: wu lx. World J Clin Cases. 2020 Jan 26;8(2):410-414. doi: 10.12998/wjcc.v8.i2.410. World J Clin Cases. 2020. PMID: 32047793 Free PMC article.

10

Dual drive coexistence of ALK rearrangement and KRAS mutation advanced lung adenocarcinoma and response to crizotinib.

Zhu YC, Wan B, Wu LX, Li XL, Wang WX, Xu CW, Zhuang W, Wei JG, Du KQ. Zhu YC, et al. Among authors: wu lx. Transl Cancer Res. 2019 Aug;8(4):1630-1634. doi: 10.21037/tcr.2019.06.23. Transl Cancer Res. 2019. PMID: 35116907 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters